OR WAIT null SECS
September 03, 2009
The US Pharmacopeial Convention (USP) and the Permanent Commission of the Pharmacopeia of the United Mexican States (FEUM) signed a memorandum of understanding (MOU) last week.
Also, Orexo and Novartis form agreement; Affitech appoints Robert Burns CEO; more...
September 02, 2009
Brief pharmaceutical news items for September 2009.
After years of promomting QbD concepts, FDA's ready to take action on nonconformers.
An outstanding new book reviews alternative solvents with an eye to sustainable pharmaceutical processes.
A second-generation and green manufacturing process for testosterone provided economic and ecological benefits.
Select contract manufacturing organizations roll out expansions for production of active pharmaceutical ingredients and intermediates.
Pfizer uses green-chemistry in a second-generation manufacturing route for gabapentin.
As new process validation guidelines emerge, industry needs to reinvent how it releases product.
IPEC's new stability testing guide takes into account the full supply chain's storage conditions.